Domů › Síňová fibrilace › Massachusetts › Boston
Klinické studie Síňová fibrilace v Boston, MA
17 studií pro Síňová fibrilace hledá účastníky v lokalitách v Boston a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Probíhá náborFáze 3
- Tufts Medical Center, Boston
- Mass General Hospital, Boston
- Brigham and Women's Hospital, Boston
- a dalších 3
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Probíhá náborFáze 2
- Beth Israel Lahey Health, Beth Israel Deaconess Medical Center (BIDMC), Boston
Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
Probíhá náborFáze 4
- Boston VA CSP Coordinating Center, Boston
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Probíhá náborObservační studie
- Brigham and Women's Hospital, Boston
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Probíhá náborFáze 2
- Massachusetts General Hospital - Cardiology, Boston
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
Probíhá nábor
- Boston University Medical Center, Boston
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Probíhá nábor
- Massachusetts General Hospital, Boston
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
Probíhá nábor
- Massachusetts General Hospital, Boston
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Probíhá náborFáze 3
- Anthos Investigative Site 9918, Boston
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Probíhá náborObservační studie
- Brigham and Women's Hospital, Boston
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Probíhá náborFáze 3
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
Probíhá náborRaná fáze 1
- Brigham and Women Hospital, Boston
Medtronic Terminate AF Study
Probíhá nábor
- Massachusetts General Hospital, Boston
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Probíhá náborFáze 3
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Boston Medical Center, Boston
- a dalších 1
Positron Emission Tomography (PET) Imaging of Thrombosis
Probíhá náborFáze 1Vítáni zdraví dobrovolníci
- Massachusetts General Hospital, Boston
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Probíhá náborObservační studie
- The Brigham and Womens Hospital, Boston
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Probíhá nábor
- Brigham and Woman's Hospital, Boston
Studie Síňová fibrilace v jiných městech
- New York City, NY21 studií
- Cleveland, OH17 studií
- Atlanta, GA16 studií
- Philadelphia, PA12 studií
- Jonesboro, AR12 studií
- Chicago, IL12 studií
- Ann Arbor, MI11 studií
- Pittsburgh, PA10 studií
- Cincinnati, OH10 studií
- Columbus, OH10 studií
- Austin, TX9 studií
- Houston, TX9 studií
Další studie v Boston
- Rakovina prsu111 studií
- Nemalobuněčný plicní karcinom90 studií
- Rakovina (všechny typy)86 studií
- Kolorektální karcinom63 studií
- Metastatický karcinom63 studií
- Rakovina plic62 studií
- Rakovina vaječníků61 studií
- Rakovina prostaty59 studií
- Deprese52 studií
- Rakovina endometria50 studií
- Srdeční selhání44 studií
- Akutní myeloidní leukemie44 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.